Cyproheptadine was not developed by Merck. It is an antihistamine and antiserotonergic drug that was developed by Lederle Laboratories.
When did Cyproheptadine become available?
Cyproheptadine was first patented in 1959 [1]. It became available as a prescription medication under the brand name Periactin in the United States in the early 1960s.
What is Cyproheptadine used for?
Cyproheptadine is primarily used to treat allergic reactions, such as hives and runny nose. It is also used off-label for appetite stimulation and to manage symptoms of certain serotonin-related conditions.
What are the alternatives to Cyproheptadine?
Other antihistamines are available for treating allergic reactions. For appetite stimulation, alternative treatments may depend on the underlying cause of appetite loss.
What are the side effects of Cyproheptadine?
Common side effects of Cyproheptadine include drowsiness, dizziness, and dry mouth. Some individuals may experience weight gain as a side effect.
Who currently manufactures Cyproheptadine?
While originally developed by Lederle Laboratories, Cyproheptadine is now manufactured and marketed by various pharmaceutical companies under different brand names and as a generic medication.
What is the patent status of Cyproheptadine?
The original patents for Cyproheptadine have long expired. Information on current patent filings or extensions for specific formulations or manufacturing processes would require a detailed search of patent databases, such as those provided by DrugPatentWatch.com [2].
Sources:
[1] https://www.drugs.com/history/periactin.html
[2] https://drugpatentwatch.com/